UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 608

Sortiert nach

Tuberculosis Treatment Monitoring and Outcome Measures: New Interest and New Strategies

Clinical microbiology reviews, 2022-09, Vol.35 (3), p.e0022721

2022

Link zum Volltext

Verfügbarkeit prüfen

Rapid and accurate detection of Mycobacterium tuberculosis in sputum samples by Cepheid Xpert MTB/RIF assay--a clinical validation study

PloS one, 2011-06, Vol.6 (6), p.e20458-e20458

2011

Link zum Volltext

Verfügbarkeit prüfen

A pre-clinical validation plan to evaluate analytical sensitivities of molecular diagnostics such as BD MAX MDR-TB, Xpert MTB/Rif Ultra and FluoroType MTB

PloS one, 2020-01, Vol.15 (1), p.e0227215-e0227215

2020

Link zum Volltext

Verfügbarkeit prüfen

Prevalence of Pulmonary Tuberculosis among Prison Inmates in Ethiopia, a Cross-Sectional Study

PloS one, 2015-12, Vol.10 (12), p.e0144040-e0144040

2015

Link zum Volltext

Verfügbarkeit prüfen

Community engagement in tuberculosis research: the EU-Patient-cEntric clinicAl tRial pLatforms (EU-PEARL) experience

International journal of infectious diseases, 2023-05, Vol.130, p.S20-S24

2023

Link zum Volltext

Verfügbarkeit prüfen

Target Product Profile for a Diagnostic Assay to Differentiate between Bacterial and Non-Bacterial Infections and Reduce Antimicrobial Overuse in Resource-Limited Settings: An Expert Consensus

PloS one, 2016-08, Vol.11 (8), p.e0161721-e0161721

2016

Link zum Volltext

Verfügbarkeit prüfen

miRNA signatures in sera of patients with active pulmonary tuberculosis

PloS one, 2013-11, Vol.8 (11), p.e80149-e80149

2013

Link zum Volltext

Verfügbarkeit prüfen

Phenotypic Changes on Mycobacterium Tuberculosis-Specific CD4 T Cells as Surrogate Markers for Tuberculosis Treatment Efficacy

Frontiers in immunology, 2018-09, Vol.9, p.2247-2247

2018

Link zum Volltext

Verfügbarkeit prüfen

Reduction of blood C-reactive protein concentration complements the resolution of sputum bacillary load in patients on anti-tuberculosis therapy

Frontiers in immunology, 2022-09, Vol.13, p.1005692-1005692

2022

Link zum Volltext

Verfügbarkeit prüfen

Seroepidemiological and molecular investigations of infections with Crimean–Congo haemorrhagic fever virus in Kazakhstan

International journal of infectious diseases, 2019-01, Vol.78, p.121-127

2019

Link zum Volltext

Verfügbarkeit prüfen

High seroprevalence of Rift Valley FEVER AND EVIDENCE FOR ENDEMIC circulation in Mbeya region, Tanzania, in a cross-sectional study

PLoS neglected tropical diseases, 2012-03, Vol.6 (3), p.e1557-e1557

2012

Link zum Volltext

Verfügbarkeit prüfen

Drug resistance and population structure of M.tuberculosis isolates from prisons and communities in Ethiopia

BMC infectious diseases, 2016-11, Vol.16 (1), p.687-687, Article 687

2016

Link zum Volltext

Verfügbarkeit prüfen

Direct Comparison of Xpert MTB/RIF Assay with Liquid and Solid Mycobacterial Culture for Quantification of Early Bactericidal Activity

Journal of Clinical Microbiology, 2013-06, Vol.51 (6), p.1894-1898

2013

Link zum Volltext

Verfügbarkeit prüfen

Seroprevalence of alphavirus antibodies in a cross-sectional study in southwestern Tanzania suggests endemic circulation of chikungunya

PLoS neglected tropical diseases, 2014-07, Vol.8 (7), p.e2979-e2979

2014

Link zum Volltext

Verfügbarkeit prüfen

High seroprevalence for typhus group rickettsiae, southwestern Tanzania

Emerging infectious diseases, 2013-02, Vol.19 (2), p.317-320

2013

Link zum Volltext

Verfügbarkeit prüfen

User perspectives and preferences on a novel TB LAM diagnostic (Fujifilm SILVAMP TB LAM)-a qualitative study in Malawi and Zambia

PLOS global public health, 2022, Vol.2 (7), p.e0000672-e0000672

2022

Link zum Volltext

Verfügbarkeit prüfen

High seroprevalence for spotted fever group rickettsiae, is associated with higher temperatures and rural environment in Mbeya region, Southwestern Tanzania

PLoS neglected tropical diseases, 2015-04, Vol.9 (4), p.e0003626-e0003626

2015

Link zum Volltext

Verfügbarkeit prüfen

Early Identification of Progressive TB Disease Using Host Biomarkers

EBioMedicine, 2015-02, Vol.2 (2), p.107-108

2015

Link zum Volltext

Verfügbarkeit prüfen

Proceedings from the CIHLMU 5th Infectious Diseases Symposium 2016 “Drug Resistant Tuberculosis: Old Disease - New Challenge”

BMC proceedings, 2017-09, Vol.11 (S10), p.0-0, Article 0

2017

Link zum Volltext

Verfügbarkeit prüfen

A dose-ranging trial to optimize the dose of rifampin in the treatment of tuberculosis

American journal of respiratory and critical care medicine, 2015-05, Vol.191 (9), p.1058-1065

2015

Link zum Volltext

Verfügbarkeit prüfen

A Systematic Review of Potential Biomarkers for Bacterial Burden and Treatment Efficacy Assessment in Tuberculosis Platform-Based Clinical Trials

The Journal of infectious diseases, 2023-11

2023

Link zum Volltext

Verfügbarkeit prüfen

Treatment Strategy for Rifampin-Susceptible Tuberculosis

The New England journal of medicine, 2023-06, Vol.388 (24), p.2297

2023

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 608

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(421)
Mit Volltextzugriff
(547)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Tuberculosis Treatment Monitoring and Outcome Measures: New Interest and New Strategies

Rapid and accurate detection of Mycobacterium tuberculosis in sputum samples by Cepheid Xpert MTB/RIF assay--a clinical validation study

A pre-clinical validation plan to evaluate analytical sensitivities of molecular diagnostics such as BD MAX MDR-TB, Xpert MTB/Rif Ultra and FluoroType MTB

Prevalence of Pulmonary Tuberculosis among Prison Inmates in Ethiopia, a Cross-Sectional Study

Community engagement in tuberculosis research: the EU-Patient-cEntric clinicAl tRial pLatforms (EU-PEARL) experience

Target Product Profile for a Diagnostic Assay to Differentiate between Bacterial and Non-Bacterial Infections and Reduce Antimicrobial Overuse in Resource-Limited Settings: An Expert Consensus

miRNA signatures in sera of patients with active pulmonary tuberculosis

Phenotypic Changes on Mycobacterium Tuberculosis-Specific CD4 T Cells as Surrogate Markers for Tuberculosis Treatment Efficacy

Reduction of blood C-reactive protein concentration complements the resolution of sputum bacillary load in patients on anti-tuberculosis therapy

Assessment of the sensitivity and specificity of Xpert MTB/RIF assay as an early sputum biomarker of response to tuberculosis treatment

Phylogenetic lineages of tuberculosis isolates and their association with patient demographics in Tanzania

Seroepidemiological and molecular investigations of infections with Crimean–Congo haemorrhagic fever virus in Kazakhstan

High seroprevalence of Rift Valley FEVER AND EVIDENCE FOR ENDEMIC circulation in Mbeya region, Tanzania, in a cross-sectional study

Drug resistance and population structure of M.tuberculosis isolates from prisons and communities in Ethiopia

Direct Comparison of Xpert MTB/RIF Assay with Liquid and Solid Mycobacterial Culture for Quantification of Early Bactericidal Activity

Seroprevalence of alphavirus antibodies in a cross-sectional study in southwestern Tanzania suggests endemic circulation of chikungunya

Regional Variation of Extended-Spectrum Beta-Lactamase (ESBL)-Producing Enterobacterales, Fluoroquinolone-Resistant Salmonella enterica and Methicillin-Resistant Staphylococcus aureus Among Febrile Patients in Sub-Saharan Africa

High seroprevalence for typhus group rickettsiae, southwestern Tanzania

User perspectives and preferences on a novel TB LAM diagnostic (Fujifilm SILVAMP TB LAM)-a qualitative study in Malawi and Zambia

High seroprevalence for spotted fever group rickettsiae, is associated with higher temperatures and rural environment in Mbeya region, Southwestern Tanzania

Early Identification of Progressive TB Disease Using Host Biomarkers

Proceedings from the CIHLMU 5th Infectious Diseases Symposium 2016 “Drug Resistant Tuberculosis: Old Disease - New Challenge”

A dose-ranging trial to optimize the dose of rifampin in the treatment of tuberculosis

A Systematic Review of Potential Biomarkers for Bacterial Burden and Treatment Efficacy Assessment in Tuberculosis Platform-Based Clinical Trials

Treatment Strategy for Rifampin-Susceptible Tuberculosis

Suchergebnisse filtern